PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34330980-8	2021	Furthermore, GSK101 increased AMPK phosphorylation and decreased IL-1beta-induced nuclear factor kappa B (NF-kappaB) phosphorylation.	N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide	13-19	nuclear factor kappa B subunit 1	Homo sapiens	82-104	
34330980-8	2021	Furthermore, GSK101 increased AMPK phosphorylation and decreased IL-1beta-induced nuclear factor kappa B (NF-kappaB) phosphorylation.	N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide	13-19	nuclear factor kappa B subunit 1	Homo sapiens	106-115	
34330980-9	2021	Compound C and STO-609 reversed the suppressive effects of GSK101 on NF-kappaB activation and MMP-13 expression.	N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide	59-65	nuclear factor kappa B subunit 1	Homo sapiens	69-78	
30022772-8	2018	GSK1016790A-induced inhibitor of kappa B-alpha (IkappaBalpha) decomposition, which causes NF-kappaB activation was suppressed by NF157 and SB203580, and gamma-irradiation-induced IkappaBalpha decomposition was suppressed by TRPV4 channel inhibitors.	N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothiophene-2-carboxamide	0-11	nuclear factor kappa B subunit 1	Homo sapiens	90-99